illegal drugs

Australia implements a new framework for regulating the medicinal use of psychedelic substances such as MDMA and psilocybin.

The government should lower regulatory hurdles impeding psilocybin assisted psychotherapy research.

Dispensaries could fill the regulatory void for psychedelics and promote public health.

Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.

Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.

Experts discuss the benefits and drawbacks of existing regulatory frameworks for psychedelics.

Pennsylvania law prevents people who use drugs from testing for fentanyl and avoiding overdoses.

Scholar argues that FDA can, and should, regulate marijuana edibles.

As the United States struggles with opioid addiction, litigation rages over medically supervised consumption facilities.